Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: Acute parotitis may predict interstitial pneumonitis

International Journal of Hematology

Volumn 83, Issue 1, 2006, Pages 86-91

  Oya, Natsuo ^a,b   Sasai, Keisuke ^a,c   Tachiiri, Seiji ^a   Sakamoto, Takashi ^a,b   Nagata, Yasushi ^a   Okada, Takashi ^a   Yano, Shinsuke ^a   Ishikawa, Takayuki ^a   Uchiyama, Takashi ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Dose rate; Interstitial pneumonitis; Lung dose; Parotitis; Total body irradiation

Indexed keywords

AMYLASE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AMYLASE BLOOD LEVEL; ARTICLE; BONE MARROW PURGING; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PAROTITIS; PREDICTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIATION SHIELD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AMYLASES; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEMATOLOGIC DISEASES; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PAROTITIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 31644431953     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05046     Document Type: Article

References (40)

1. Bieri S, Helg C, Chapuis B, Miralbell R. Total body irradiation before allogeneic bone marrow transplantation: is more dose better? Int J Radiat Oncol Biol Phys. 2001;49:1071-1077.
2. Girinsky T, Benhamou E, Bourhis JH, et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol. 2000;18:981-986.
3. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol. 2002;76(suppl 2):15-28.
4. Aristei C, Aversa F, Chionne F, Martelli MF, Latini P. Interstitial pneumonitis in acute leukemia patients submitted to T-depleted matched and mismatched bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1998;41:651-657.
5. Carlson K, Backlund L, Smedmyr B, Oberg G, Simonsson B. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant. 1994;14:805-811.
6. Chen CI, Abraham R, Tsang R, Crump M, Keating A, Stewart AK. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant. 2001;27:177-182.
7. Cosset JM, Baume D, Pico JL. et al. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol. 1989;15:151-160.
8. Della Volpe A, Ferreri AJ, Annaloro C, et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys. 2002;52:483-488.
9. Demirer T, Petersen FB, Appelbaum FR, et al. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a phase I/II trial. Int J Radiat Oncol Biol Phys. 1995;32:1103-1109.
10. Gerrard GE, Vail A, Taylor RE, et al. Toxicity and dosimetry of fractionated total body irradiation prior to allogeneic bone marrow transplantation using a straightforward radiotherapy technique. Clin Oncol (R Coll Radiat). 1998;10:379-383.
11. Gopal R, Ha CS, Tucker SL, et al. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer. 2001;92:1949-1958.
12. Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996;36:67-75.
13. Hartsell WF, Czyzewski EA, Ghalie R, Kaizer H, Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Int J Radiat Oncol Biol Phys. 1995;32:69-73.
14. Hjiyiannakis P, Mehta J, Milan S, Powles R, Hinson J, Tait D, Melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortality. Leuk Lymphoma. 1997;25:565-572.
15. Inoue T, Ikeda H, Yamazaki H, et al. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Strahlenther Onkol. 1993;169:250-255.
16. Kader HA, Khanna S, Hutchinson RM, Aukett RJ, Archer J. Pulmonary complications of bone marrow transplantation: the impact of variations in total body irradiation parameters. Clin Oncol (R Coll Radiol). 1994;6:96-101.
17. Labar B, Bogdanic V, Nemet D, et al. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Bone Marrow Transplant. 1992;9:343-347.
18. McAfee SL, Powell SN, Colby C, Spitzer TR. Dose-escalated total body irradiation and aulologous stem cell transplantation for refractory hematologic malignancy. Int J Radiat Oncol Biol Phys. 2002;53:151-156.
19. Morgan TL, Falk PM, Kogut N, Shah KH, Tome M, Kagan AR. A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996;36:61-66.
20. Ott M, Schmidberger H, Wormann B, Albrecht CF, Pradier O, Hess CF. Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma. Strahlenther Onkol. 2002;178:245-251.
21. Ozsahin M, Belkacemi Y, Pene F, et al. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. InI J Radiat Oncol Biol Phys. 1996;34:71-77.
22. Sobecks RM, Daugherty CK, Hallahan DE, Laport GF, Wagner ND, Larson RA. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies. Bone Marrow Transplant. 2000;25:807-813.
23. Thomas O, Mahe M, Campion L, et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys. 2001;49:125-131.
24. Belkacemi Y, Pene F, Touboul E, et al. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission: results and prognostic factors in 326 consecutive patients. Strahlenther Onkol. 1998;174:92-104.
25. Piroth MD, Zierhut D, van Kampen M, Sroka-Perez G, Wannenmacher M. Lung dose depending on exact patient positioning during total body irradiation (TBI): isoeffectiveness considerations to assess the risk of interstitial pneumonia after TBI. Strahlenther Onkol. 2002;178:43-49.
26. Resbeut M, Cowen D, Blaise D, et al. Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? Int J Radiat Oncol Biol Phys. 1995;31:509-517.
27. Gogna NK, Morgan G, Downs K, Atkinson K, Biggs J. Lung dose rate and interstitial pneumonitis in total body irradiation for bone marrow transplantation. Australas Radiol. 1992;36:317-320.
28. Ashida T, Higashishiba M, Sumimoto Y, et al. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation. Int J Hematol. 2001;74:464-468.
29. Matsunaga T, Sakamaki S, Ishigaki S, et al. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients. Int J Hematol. 1999;69:105-111.
30. Alyea E, Neuberg D, Mauch P, et al. Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2002;8:139-144.
31. Szekely J, Esik O. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. Strahlenther Onkol. 2000;176:584-585.
32. Safwat A, Nielsen OS, El-Badawy S, Overgaard J. Effect of radiation dose rate and cyclophosphamide on pulmonary loxicity after total body irradiation in a mouse model. Int J Radiat Oncol Biol Phys. 1996;34:85-91.
33. Barrett A, Jacobs A, Kohn J, Raymond J, Powles RL. Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed). 1982;285:170-171.
34. Becciolini A, Giannardi G, Cionini L, Porciani S, Fallai C, Pirtoli L. Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands. Acta Radiol Oncol. 1984;23:9-14.
35. Brattstrom C, Tollemar J, Ringden O, Bergstrom K, Tyden G. Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease. Transpl Int. 1991;4:96-98.
36. Dubray B, Girinski T, Thames HD, et al. Post-irradiation hyperamylasemia as a biological dosimeter. Radiother Oncol. 1992;24:21-26.
37. Hofmann R, Schreiber GA, Willich N, Westhaus R, Bogl KW. Increased serum amylase in patients after radiotherapy as a probable bioindicator for radiation exposure. Strahlenther Onkol. 1990;166:688-695.
38. Junglee D, Katrak A, Mohiuddin J, Blacklock H, Prentice HG, Dandona P. Salivary amylase and pancreatic enzymes in serum after total body irradiation. Clin Chem. 1986;32:609-610.
39. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4:529-536.
40. Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2001;49:641-648.